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Glutathione (GSH) protects rat liver microsomes against ascorbic acid (0.2 mM)/ferrous iron (10 pM)- 
induced lipid peroxidation for some time. The inhibitory effect of GSH is concentration-dependent 
(0.1-1.0 mM). Our data suggest hat GSH acts by preventing initial radical formation rather than via 
radical scavenging or GSH-peroxidase activity. A labile GSH-dependent factor is involved in the 
inhibition of microsomal lipid peroxidation by GSH, inasmuch as heating the microsomes abolishes the 
GSH effect. We found that besides heating, lipid peroxidation also destroys the GSH-dependent factor. 
Consequently, continuous radical stress will produce lipid peroxidation, despite the presence of GSH. 
Moreover, a detrimental effect of in vivo-induced lipid peroxidation (CCL-treatment) on the GSH- 
dependent factor was observed. The implications of the present data for the genesis of and the protection 
against peroxidative damage are discussed. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Lipid peroxidation has been implicated as a ma- 
jor process in cellular damage [l]. Reduced 
glutathione (GSH) is considered to be a potent in- 
hibitor of lipid peroxidation, but the mechanisms 
by which it carries out this function are not clear. 
The protective action of cytosolic glutathione 
peroxidase and glutathione transferase has been 
questioned. Both enzymes do not reduce 
microsomal lipid peroxides at a measurable rate 
[2,3]. It has also been stated that the glutathione- 
dependent cytosolic factor which inhibits lipid 
peroxidation in biological membranes does so by 
preventing radical attack on the polyunsaturated 
fatty acids. Here, the activity of GSH in 
microsomal lipid peroxidation is evaluated. 
* To whom correspondence should be addressed 
2.1. Chemicals 
Glutathione and thiobarbituric acid were obtain- 
ed from Merck (Darmstadt). All other chemicals 
used were of analytical grade purity. 
2.2. Preparation of microsomes 
Male Wistar rats (T.N.O., Zeist), 200-250 g, 
were killed by decapitation. Livers were removed 
and homogenized (1: 2, w/v) in ice-cold phosphate 
buffer (50 mM, pH 7.4) containing 0.1 mM 
EDTA. The homogenate was centrifuged at 
10000 x g (20 min at 4’C). Subsequently the 
supernatant was centrifuged at 10000 x g (20 min) 
and again at 65000 x g (60 min). The microsomal 
pellet was resuspended in the phosphate buffer (2 g 
liver/ml) and stored at -80°C. Before use the 
microsomes were thawed and diluted 5-fold with 
ice-cold Tris-HCl buffer (50 mM, pH 7.4) con- 
taining 150 mM KC1 and washed twice with cen- 
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trifugation at 115000 x g (40 min). Finally the 
pellet was resuspended in the Tris buffer and used. 
2.3. Pretreatment of rats 
Carbon tetrachloride (CC4) pretreatment con- 
sisted of the oral administration of a CCL/corn oil 
(SO%, v/v) solution (5 ml/kg). Water and food 
were provided ad libitum. After 18 h liver micro- 
somes were prepared as in section 2.2, but were less 
diluted in order to get the same protein concentra- 
tion as in the control incubations. 
Starvation consisted of a period of 18 h food 
deprivation before decapitation. Water was given 
ad libitum, Phorone treatment was as in [4], 
250 mg/kg i.p., and decapitation after 2 h. 
2.4. Incubation conditions 
Microsomes (final cont. r/s g liver/ml) were in- 
cubated at 37”C, with shaking air being freely ad- 
mitted in Tris-HCl/KCl (50 mM/150 mM, pH 
7.4). Ascorbic acid and GSH were neutralized with 
KOH before addition. Reactions were started by 
adding a freshly prepared FeS04 solution. 
2.5. Spectral measurements 
Lipid peroxidation was assayed by measuring 
t~obarbituric acid (TBA) reactive material. An 
aliquot of the incubation (0.3 ml) was stopped by 
mixing with ice-cold TBA-trichloroacetic acid- 
HCl-butylhydroxytoluene (BHT) solution (2 ml). 
After heating (15 min, 8OY.J) and centrifugation 
(15 min) the absorbance at 535 nm vs 600 nm was 
determined. The TBA-trichloroacetic acid-HCl 
solution was prepared by dissolving 41.6 mg 
TBA/lO ml trichloroacetic acid (16.8% w/v in 
0.125 N HCl). To 10 ml TBA-trichloroacetic 
acid-HCI 1 ml BHT (1.5 mg/ml ethanol) was add- 
ed. The added chemicals did not interfere with the 
assay in the concentrations used. 
Thiol determination was performed after [5]. 
Corrections were made for the absorbance produc- 
ed by iron. Microsomal protein was assayed as in 
[6], using bovine serum albumin as standard. 
3. RESULTS 
GSH protects rat liver microsomes against lipid 
peroxidation promoted by ascorbic acid and fer- 
rous iron in a concentration-de~ndent manner 
Fig.1. Inffuence of GSH on the time course of lipid 
peroxidation. Microsomes (1.3 mg protei~ml) were 
incubated with 0.2 mM ascorbate. [GSH] was 0 mM 
(o), 0.1 mM (a), 0.2 mM (A), 0.5 mM (0). 1 mM (a). 
Reactions were started with addition of Fe’+ (10,~M). 
Data represent one example out of at least 4 duplicate 
expt. 
(fig.1). This protective effect of GSH is abolished 
by heating the microsomes in boiling water for 90 s 
(fig.2). This indicates the involvement of (a) 
microsomal heat-labile factor(s) in the GSH effect 
(71. 
To investigate the GSH ~nsumption during 
15 20 30 45 
- mcubation time Imm.l 
Fig.2. Time course of lipid peroxidation. The reaction 
mixture consisted of heated microsomes (1.3 mg 
protein/ml, before heating) 0.2 mM ascorbate (o), 
0.2 mM ascorbate and 1 mM GSH (w), no addition 
(0), 1 mM GSH (0). All reactions were initiated with 
addition of Fe2’. Data represent one example out of at 
least 4 duplicate expt. 
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Fig.3. Time course of lipid peroxidation (- ) and Fig.4. Time course of lipid perotidation. Microsomes 
thiol concentrations ( - = -). Microsomes (1.2 mg pro- (1 .l mg protein/ml) were incubated with 0.05 mM 
tein/~) were incubated with 0.2 mM ascorbate (o), ascorbate. The reaction was started with the addition of 
0.2 mM ascorbate and 1 mM GSH (m) with (A) as the Fe”’ (IOpM). After 12.5 min the following additions 
corresponding thiol concentration, no addition (0), were made: 0.05 mM ascorbate and 1 mM GSH (o), 
1 mM GSH (U), with (A) as the’ corresponding thiol 0.05 mM ascorbate and the same volume of Tris buffer 
concentration. All reactions were started with addition which was needed for GSH (0), 1 mM GSH (m), none 
of Fe’+. Data represent one example out of 2 duplicate (A). Appropriate corrections were made for changes in 
experiments. volume. 
lipid peroxidation the TBA-test has been combined 
with a thiol determination (fig.3). The results of 
fig. 1 and 3 show that GSH delays but does not pre- 
vent lipid peroxidation. After a lag time a strong 
increase in TBA-reactive material is observed, 
whereas GSH-levels remain relatively high. In 
order to explain the rise in lipid peroxidation which 
eventually occurs, notwithstanding the presence of 
GSH, we thought that the GSH-dependent lipid 
pero~dation inhibit~g factor(s) may be destroyed 
during initial but persistent stress. To investigate 
the notion, the GSH protection after moderate 
lipid peroxidation has been examined (fig.4). No 
protection by GSH is observed (fig.4) indicating 
that the factor(s) is(are) indeed destroyed during 
lipid peroxidation. 
Furthermore, we investigated the stability of the 
factor(s) in vivo. Pretreatment of rats with CC4 
resulted in a diminished protective effect of GSH 
in microsomal incubates compared with the effect 
observed in hepatic microsomes obtained from oil 
pretreated (control) rats. Also, GSH depletion in- 
duced by pretreatment with phorone [4] or by star- 
vation [S], reduced the protection by GSH in 
microsomes, compared with results established in 
hepatic microsomes from untreated rats (not 
shown). 
Y 
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4. DISCUSSION 
The effect of GSH on ascorbate/iron induced 
~crosom~ lipid peroxidation is studied. Ascorbic 
acid (0.2 mM) does not stimulate lipid peroxida- 
tion in the absence of iron, nor does ferric iron 
(10 FM) in the absence of ascorbic acid. Ascorbic 
acid added in combination with ferric iron results 
in substantial lipid peroxidation (not shown). Tak- 
ing this into account, as well as the fact that fer- 
rous iron is capable of promoting lipid peroxida- 
tion (fig.2,3), the role of ascorbic acid appears to 
be maintenance of iron in the reduced (ferrous) 
form [9]. The stimulation of lipid peroxidation 
produced by GSH in a system containing heated 
microsomes, ascorbic acid and ferrous iron (fig.2) 
can be explained by the regeneration of ascorbic 
acid by GSH, inasmuch as GSH is able to reduce 
dehydroascorbic acid to ascorbic acid. This reac- 
tion however, has probably no significance in vivo 
[lo]. Without ascorbic acid, GSH does not 
stimulate, indicating that GSH itself does not 
reduce trivalent iron at a measurable rate [ 111 
(fig.2). In the system containing ascorbic acid, fer- 
rous iron and microsomes; ascorbic acid becomes 
irreversibly oxidized since it is shown that addition 
of GSH, 12.5 min after ferrous iron, does not 
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enhance formation of TBA-reactive material 
(fig.4) [12]. 
Microsomal ipid peroxidation is inhibited by 
GSH (fig.1). GSH acts by preventing radical for- 
mation. The protection by GSH is not due to 
radical scavenging or GSH-peroxidase activity 
because in that case: 
0) 
(ii) 
A decline in GSH levels should be observed 
during the lag phase. The decrease in GSH 
levels per se will lead to enhancement of lipid 
peroxidation. However, we did not observe a 
subst~ti~ consumption of GSH (fig.3) which 
would bring GSH levels under scavenging 
concentration. 
Maximal ipid peroxidation should not be the 
same in peroxidising microsomes with and 
without GSH. Our results however demon- 
strated the same xtent of ~ro~dation in both 
systems (fig. 1,3). 
Protection by GSH proceeds via a heat-labile 
microsomal factor (fig.2). Apparently, also a con- 
tinuous radical stress (fig. 1,3) or lipid peroxidation 
(fig.4) affects the GSH-dependent factor. 
Recently the influence of ~-tocopherol (vitamin 
E) on ascorbateliron-induced peroxidation in 
liposomes was thoroughly studied [13]. One 
molecule of cu-tocopherol was found to be able to 
protect even 220 molecules of polyunsaturated fat- 
ty acids. Moreover, it was stated that cr-tocopherol 
may prevent radical formation without undergoing 
any measurable oxidation itself. Our results in- 
dicate that GSH also acts via inhibition of radical 
formation. It is therefore tempting to suggest an 
interaction between the water-soluble GSH and the 
~pid-soluble vitamin El comparable to the presum- 
ed linkage between vitamins C and E [14]: 
h f ‘&or ‘3\ 
RJ/ Ivit.E*-/ LGSH 
Liver microsomes of vitamin E-deficient rats are 
devoid of a protective ffect by GSH [15]. The 
conclusion was therefore reached that i~ibition 
by GSH is vitamin E-dependent. However, vitamin 
E depletion has been found to produce an enhanc- 
ed ethane xhalation i  rats [ 161. Since the latter is 
an index of lipid peroxidation, the inability of 
GSH to protect might be explained by the destruc- 
tion of the labile factor. In our opinion so far no 
direct evidence for the vitamin E dependency of 
the protective ffect by GSH has been adduced. If 
vitamin E does play a role, it is certainly not the 
only component since in heated microsomes the in- 
hibition by GSH is eliminated, whereas heating has 
no effect on the vitamin E level [15]. 
Attempts have been made to isolate GSH- 
dependent protective factor(s). In [17,18] the in- 
vestigators claimed to have isolated a GSH- 
dependent peroxidation inhibiting protein (PIP). 
Pecufiarly however, they abserved no protective 
effect by GSH in intact microsomes. Furthermore 
the action of PIP was ascribed to its capacity to 
reduce hydroperoxide derivatives of phospho- 
lipids, at the expense of GSH. Our data suggest 
another protective mechanism by GSH. 
We also demonstrated the instability of the 
GSH-dependent protective factor(s) in vivo. A 
decreased protection by GSH is obtained in vitro, 
using hepatic microsomes from CC4-pretreated 
rats (fig.5). 
2.5 5 10 15 20 
incubation time (min.) 
Fig.5. Percentage change in lipid peroxidation using a 
system containing microsomes, 0.2 mM ascorbate, 
1 mM GSH and 10pM Fez+ compared with the lipid 
peroxidation without GSH, measured at several 
incubation times. Each data point represents the mean 
of a duplicate experiment in which liver microsomes 
were prepared from one rat. O&pretreated control rats 
(0) (1.3-1.6 mg protein/ml) and CC&-pretreated rats 
(0) (1.2-l .9 mg protein/ml). 
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The chain reaction of microsomal lipid perox- 
idation might be initiated after destruction of the 
GSH-dependent peroxidation inhibiting factor(s). 
Our results suggest that in that stage the pro- 
gressive adverse membrane damage cannot be 
reversed via a direct or indirect increase of GSH 
levels. This is of importance in order to be able to 
provide adequate measures against hepatotoxic 
effects of many xenobiotics which give lipid 
peroxidation. 
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